
Medically Reviewed By
Dr. Neha Gupta ( Medical Oncology)
A compassionate, evidence-based daycare clinical oncology guide on Automated Scalp Cooling Systems (DigniCap, Paxman), detailing cutaneous vasoconstriction, reduced cellular drug uptake, hair follicle metabolic dormancy, and preservation protocols in breast and solid tumor chemotherapy.
CRITICAL CLINICAL RED FLAG: Chemotherapy-Induced Alopecia (CIA) is recognized as one of the most psychologically distressing adverse effects in cancer therapy, causing severe emotional trauma and treatment anxiety in up to 75% of patients.
Chemotherapeutic agents (Taxanes: Paclitaxel, Docetaxel; Anthracyclines: Doxorubicin, Cyclophosphamide) target rapidly dividing cells. Because 90% of scalp hair follicles are in the active mitotic growth phase (Anagen), they are acutely vulnerable to cytotoxic drug-induced apoptosis and complete hair loss.
Hair Follicle Kinetics: High metabolic activity and microvascular blood flow expose matrix keratinocytes to peak circulating drug levels.
Psychosocial Burden: Hair loss serves as a public marker of cancer, impacting self-esteem, body image, and workplace confidence.
Automated scalp cooling systems circulate temperature-controlled coolant through an insulated silicone cap to maintain scalp subcutaneous temperature at 18°C to 22°C:
Local Vasoconstriction: Constricts scalp capillaries, reducing blood flow and delivering up to 70% less chemotherapy to hair follicle roots during peak drug concentration.
Reduced Intracellular Drug Uptake: Low temperatures downregulate active cellular endocytosis and drug transport across follicle membranes.
Cellular Metabolic Dormancy: Mitotic division of follicular stem cells slows dramatically, conferring resistance against chemical cytotoxicity.
"Preserving hair during chemotherapy with scalp cooling protects patient privacy, preserves emotional dignity, and helps patients look and feel like themselves throughout treatment." — Dr. Neha Gupta

The pre-cooled cap is fitted snugly 30 minutes prior to chemotherapy infusion, maintained continuously throughout the infusion, and continued for 60 to 90 minutes post-infusion to clear circulating drug peaks.
CLINICAL CAUTION: Scalp cooling is contraindicated in hematologic malignancies (leukemia, lymphoma), active scalp metastases, cold agglutinin disease, or severe cold sensitivity.
Randomized clinical trials demonstrate that >50% to 65% of patients retain acceptable hair volume requiring no wig or head covering post-chemotherapy.
1. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy (SCALP Trial) — JAMA, 2017; 317(6): 596-605.
2. Scalp Cooling for Hair Preservation in Solid Tumor Chemotherapy: ASCO Quality Practice Update — JCO Oncol Pract, 2021; 17(8): e1200-e1208.

Senior Consultant & Clinical Director — Medical Oncology
MBBS (BFUHS Faridkot), MD Radiation Oncology (BFUHS Faridkot), DrNB Medical Oncology (Sarvodaya Hospital, Faridabad), Precision Oncology (Harvard, USA), Ex Consultant RGCI New Delhi

13+ Years Experience
Spica — Grover Hospital
Request a priority OPD appointment or second opinion on your scans.
Proprietary surgical methodologies and precision protocols pioneered by our senior directors to minimize trauma, protect natural anatomy, and accelerate recovery.

Dr. Deepak Garg (Orthopaedic Surgical Oncology - RGCI Delhi Trained) and Dr. Neha Gupta (Medical Oncology) co-lead the Bone Cancer & Sarcoma Center at Spica Healthcare. Integrating intensive multi-agent neoadjuvant chemotherapy protocols (MAP: High-Dose Methotrexate, Doxorubicin, Cisplatin for Osteosarcoma; VIDE: Vincristine, Ifosfamide, Doxorubicin, Etoposide for Ewing Sarcoma) with 3D computer-navigated limb salvage surgery and modular titanium megaprosthetic joint reconstruction, 5-year survival rates exceed 75% to 80% while saving over 95% of patients from limb amputation.
Spica Healthcare — Bone and Cancer Institute, Bathinda — is South-Western Punjab's premier super-speciality centre led by AIIMS and Tata Memorial fellowship-trained directors.
Every diagnostic MRI review, surgical staging, and operation is personally directed by chief clinical specialists — Dr. Deepak Garg (Orthopaedic Oncology & Robotics) and Dr. Neha Gupta (Medical Oncology) — guaranteeing zero junior proxies.
Sub-millimeter implant positioning and soft-tissue ligament balancing ensuring patients walk comfortably within 24 hours of total knee replacement.
South-West Punjab's only dedicated centre for modular titanium megaprosthesis, saving natural limbs and functions in 95%+ of bone cancer patients.
Full cashless coverage for Ayushman Bharat (PM-JAY), Punjab Govt Health Schemes, ECHS, and 30+ private insurance networks with on-desk approvals.
Positive-pressure HEPA filtered theatres minimizing infection rates below international benchmarks with 24/7 dedicated critical care backup.
Fellowship-trained surgical directors from AIIMS & Tata Memorial providing compassionate, world-class tertiary care in super-speciality orthopaedics and medical oncology.

Senior Consultant & Clinical Director — Medical Oncology
MBBS (BFUHS Faridkot), MD Radiation Oncology (BFUHS Faridkot), DrNB Medical Oncology (Sarvodaya Hospital, Faridabad), Precision Oncology (Harvard, USA), Ex Consultant RGCI New Delhi


Senior Consultant & Clinical Director — Orthopaedic Oncology & Robotic Joint Surgery
16+ Yrs ExpSenior Consultant & Clinical Director — Orthopaedic Oncology & Robotic Joint Surgery
MBBS (TNMC Mumbai), DNB Orthopaedics (PGI & SP Miraj), Fellowship Arthroplasty and Arthroscopy (Fortis Hospital, New Delhi), Fellowship Orthopaedic Oncology (Rajiv Gandhi Cancer Institute, New Delhi)
Free OPD screening camps, director-led masterclasses, and national oncology representations by Spica Healthcare.
Real stories from patients who recovered through limb preservation surgery, 3D robotic joint replacements, and precision cancer care at Spica Healthcare — Grover Hospital, Bathinda.
Evidence-based surgical recovery roadmaps, robotic joint protocols, and precision oncology insights written by our clinical directors.